Cargando…
Long-Term Treatment Outcomes in Type 3 Neovascularization: Focus on the Difference in Outcomes between Geographic Atrophy and Fibrotic Scarring
Background: To evaluate the difference in the long-term treatment outcomes of type 3 neovascularization between eyes with geographic atrophy and those with fibrotic scars. Methods: This retrospective study included 195 eyes diagnosed with type 3 neovascularization and treated with anti-vascular endo...
Autores principales: | Kim, Jae Hui, Kim, Jong Woo, Kim, Chul Gu, Lee, Dong Won |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230588/ https://www.ncbi.nlm.nih.gov/pubmed/32316276 http://dx.doi.org/10.3390/jcm9041145 |
Ejemplares similares
-
Prechoroidal Cleft in Type 3 Neovascularization: Incidence, Timing, and Its Association with Visual Outcome
por: Kim, Jae Hui, et al.
Publicado: (2018) -
Long-term Clinical Course after Vitrectomy for Breakthrough Vitreous Hemorrhage Secondary to Neovascular Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy
por: Kim, Jae Hui, et al.
Publicado: (2020) -
Increase in the Population of Patients with Neovascular Age-Related Macular Degeneration Who Underwent Long-Term Active Treatment
por: Baek, Seung Kook, et al.
Publicado: (2019) -
Comparison of 24-month treatment outcomes between as-needed treatment and switching to treat-and-extend in type 3 macular neovascularization
por: Kim, Jae Hui, et al.
Publicado: (2022) -
Author Correction: Increase in the Population of Patients with Neovascular Age-Related Macular Degeneration Who Underwent Long-Term Active Treatment
por: Baek, Seung Kook, et al.
Publicado: (2020)